Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes
2016 · The Breast · 46 citations
https://doi.org/10.1016/j.breast.2016.08.003
K
Keiko Murase
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
479
Citations
13
h-index
16
i10-index
Keiko Murase is an academic researcher from Hyogo Medical University. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Cancer Cells and Metastasis. The author has an h-index of 13, co-authored 27 publications.
Papers by this author
worksInfluence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers
2013 · International Journal of Clinical Oncology · 18 citations
https://doi.org/10.1007/s10147-013-0585-y
Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers
2012 · Breast Cancer · 14 citations
https://doi.org/10.1007/s12282-012-0348-z
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women
2013 · Breast Cancer · 13 citations
https://doi.org/10.1007/s12282-013-0493-z
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer
2024 · International Journal of Clinical Oncology · 6 citations
https://doi.org/10.1007/s10147-024-02625-w
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy
2025 · Breast Cancer · 1 citations
https://doi.org/10.1007/s12282-025-01665-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat